Condition: Dissection of Thoracic Aorta · Dissection of Thoracic Descending Aorta · Aneurysm of Aorta, Thoracic · Sponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.
This description comes directly from the study's public registry record.
Maggie Shen, MD MSc · 00441235750800 · maggie.shen@endovastec-lm.com
Anne Woodman · 00441235750800 · anne.woodman@endovastec-lm.com
Always discuss trial participation with your own doctor first.
| ASKLEPIOS Kliniken St. Georg | Hamburg, Germany | Recruiting |
| Universitätsklinikum Münster (UKM) | Münster, Germany | Recruiting |
| Hôpital de Sion | Sion, Switzerland | Recruiting |
| Universitätsspital Zürich (USZ) | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07668687